GeneDx Holdings Corp. (WGS) Cash from financing

annual CFF:

$44.16M-$142.08M(-76.29%)
December 31, 2024

Summary

  • As of today (September 10, 2025), WGS annual cash flow from financing activities is $44.16 million, with the most recent change of -$142.08 million (-76.29%) on December 31, 2024.
  • During the last 3 years, WGS annual CFF has fallen by -$449.57 million (-91.06%).
  • WGS annual CFF is now -91.06% below its all-time high of $493.73 million, reached on December 31, 2021.

Performance

WGS Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWGScash flow metrics

quarterly CFF:

$346.00K-$13.37M(-97.48%)
June 30, 2025

Summary

  • As of today (September 10, 2025), WGS quarterly cash flow from financing activities is $346.00 thousand, with the most recent change of -$13.37 million (-97.48%) on June 30, 2025.
  • Over the past year, WGS quarterly CFF has increased by +$737.00 thousand (+188.49%).
  • WGS quarterly CFF is now -99.93% below its all-time high of $499.40 million, reached on September 1, 2021.

Performance

WGS quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWGScash flow metrics

TTM CFF:

$59.05M+$737.00K(+1.26%)
June 30, 2025

Summary

  • As of today (September 10, 2025), WGS TTM cash flow from financing activities is $59.05 million, with the most recent change of +$737.00 thousand (+1.26%) on June 30, 2025.
  • Over the past year, WGS TTM CFF has increased by +$13.69 million (+30.18%).
  • WGS TTM CFF is now -91.52% below its all-time high of $696.81 million, reached on June 1, 2022.

Performance

WGS TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWGScash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

WGS Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-76.3%+188.5%+30.2%
3 y3 years-91.1%-99.8%-91.5%
5 y5 years-70.2%--

WGS Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-91.1%at low-99.8%+138.0%-91.5%+33.7%
5 y5-year-91.1%at low-99.9%+114.6%-91.5%+1222.0%
alltimeall time-91.1%at low-99.9%+114.6%-91.5%+1222.0%

WGS Cash from financing History

DateAnnualQuarterlyTTM
Jun 2025
-
$346.00K(-97.5%)
$59.05M(+1.3%)
Mar 2025
-
$13.72M(-55.8%)
$58.32M(+32.1%)
Dec 2024
$44.16M(-76.3%)
$31.02M(+122.1%)
$44.16M(-26.7%)
Sep 2024
-
$13.97M(-3672.4%)
$60.24M(+32.8%)
Jun 2024
-
-$391.00K(-10.7%)
$45.36M(-14.6%)
Mar 2024
-
-$438.00K(-100.9%)
$53.14M(-71.5%)
Dec 2023
$186.24M(-5.6%)
$47.10M(-5270.5%)
$186.24M(+33.8%)
Sep 2023
-
-$911.00K(-112.3%)
$139.20M(-0.2%)
Jun 2023
-
$7.39M(-94.4%)
$139.46M(-57.8%)
Mar 2023
-
$132.66M(>+9900.0%)
$330.13M(+67.3%)
DateAnnualQuarterlyTTM
Dec 2022
$197.31M(-60.0%)
$65.00K(-110.0%)
$197.31M(+0.3%)
Sep 2022
-
-$647.00K(-100.3%)
$196.76M(-71.8%)
Jun 2022
-
$198.06M(<-9900.0%)
$696.81M(+40.4%)
Mar 2022
-
-$160.00K(-67.5%)
$496.38M(+0.4%)
Dec 2021
$493.73M(+282.6%)
-
-
Dec 2021
-
-$492.00K(-100.1%)
$494.27M(-1.9%)
Sep 2021
-
$499.40M(<-9900.0%)
$503.87M(>+9900.0%)
Jun 2021
-
-$2.37M(+4.0%)
$4.47M(-34.7%)
Mar 2021
-
-$2.28M(-125.0%)
$6.84M(-25.0%)
Dec 2020
$129.06M(-12.8%)
$9.11M
$9.11M
Dec 2019
$148.01M
-
-

FAQ

  • What is GeneDx Holdings Corp. annual cash flow from financing activities?
  • What is the all time high annual CFF for GeneDx Holdings Corp.?
  • What is GeneDx Holdings Corp. annual CFF year-on-year change?
  • What is GeneDx Holdings Corp. quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for GeneDx Holdings Corp.?
  • What is GeneDx Holdings Corp. quarterly CFF year-on-year change?
  • What is GeneDx Holdings Corp. TTM cash flow from financing activities?
  • What is the all time high TTM CFF for GeneDx Holdings Corp.?
  • What is GeneDx Holdings Corp. TTM CFF year-on-year change?

What is GeneDx Holdings Corp. annual cash flow from financing activities?

The current annual CFF of WGS is $44.16M

What is the all time high annual CFF for GeneDx Holdings Corp.?

GeneDx Holdings Corp. all-time high annual cash flow from financing activities is $493.73M

What is GeneDx Holdings Corp. annual CFF year-on-year change?

Over the past year, WGS annual cash flow from financing activities has changed by -$142.08M (-76.29%)

What is GeneDx Holdings Corp. quarterly cash flow from financing activities?

The current quarterly CFF of WGS is $346.00K

What is the all time high quarterly CFF for GeneDx Holdings Corp.?

GeneDx Holdings Corp. all-time high quarterly cash flow from financing activities is $499.40M

What is GeneDx Holdings Corp. quarterly CFF year-on-year change?

Over the past year, WGS quarterly cash flow from financing activities has changed by +$737.00K (+188.49%)

What is GeneDx Holdings Corp. TTM cash flow from financing activities?

The current TTM CFF of WGS is $59.05M

What is the all time high TTM CFF for GeneDx Holdings Corp.?

GeneDx Holdings Corp. all-time high TTM cash flow from financing activities is $696.81M

What is GeneDx Holdings Corp. TTM CFF year-on-year change?

Over the past year, WGS TTM cash flow from financing activities has changed by +$13.69M (+30.18%)
On this page